Advanced

Mitogen-activated protein kinase inhibition reveals differences in signalling pathways activated by neurotrophin-3 and other growth-stimulating conditions of adult mouse dorsal root ganglia neurons.

Wiklund, Peter ; Ekström, Per LU and Edström, Anders LU (2002) In Journal of Neuroscience Research 67(1). p.62-68
Abstract
PD98059 blocks mitogen-activated protein kinase (MAPK) by inhibiting its activator, MAP kinase kinase (MEK). We have previously found that PD98059 only transiently inhibits spontaneous axonal outgrowth from adult mouse dorsal root ganglia (DRG) explants, whereas it causes sustained inhibition of nerve growth factor (NGF)-stimulated growth. Surprisingly, the present results showed that outgrowth stimulation by neurotrophin-3 (NT-3), interacting with another neuronal subgroup, was markedly enhanced by PD98059 and also by U0126, another inhibitor of MAPK activation. In contrast, the effects of glial cell line-derived neurotrophic factor (GDNF), which stimulates still another subgroup of DRG neurons, was opposed by PD98059. Axonal outgrowth in... (More)
PD98059 blocks mitogen-activated protein kinase (MAPK) by inhibiting its activator, MAP kinase kinase (MEK). We have previously found that PD98059 only transiently inhibits spontaneous axonal outgrowth from adult mouse dorsal root ganglia (DRG) explants, whereas it causes sustained inhibition of nerve growth factor (NGF)-stimulated growth. Surprisingly, the present results showed that outgrowth stimulation by neurotrophin-3 (NT-3), interacting with another neuronal subgroup, was markedly enhanced by PD98059 and also by U0126, another inhibitor of MAPK activation. In contrast, the effects of glial cell line-derived neurotrophic factor (GDNF), which stimulates still another subgroup of DRG neurons, was opposed by PD98059. Axonal outgrowth in vitro can also be strongly increased by a prior axotomy in vivo. The increased outgrowth in preaxotomized explants was effectively inhibited by the presence of PD98059. Immunocytochemistry based on whole-mount labelling revealed the presence of neuronal MAPK, which was found to be activated by NGF, NT-3, and GDNF in separate axonal populations and by a prior axotomy in a majority of growing axons. The results suggest that there are important differences in the NGF and NT-3 signalling pathways, which may involve positive and negative control mechanisms by MAPK activation, respectively. Other findings indicate that GDNF exerts its growth effects by activation of MAPK and that expression of the conditioning effect in vitro in preaxotomized preparations also requires activation of MAPK. (Less)
Please use this url to cite or link to this publication:
author
; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Mitogen-Activated Protein Kinases : antagonists & inhibitors : metabolism, Mice Inbred Strains, Mice, Male, MAP Kinase Signaling System : drug effects : physiology, Immunohistochemistry, Growth Cones : drug effects : enzymology, Ganglia Spinal/drug effects : enzymology : growth & development, Flavones : pharmacology, Female, Enzyme Inhibitors : pharmacology, Comparative Study, Cells Cultured, Animal, Axotomy, Nerve Crush, Nerve Regeneration : drug effects : physiology, Nerve Tissue Proteins : metabolism : pharmacology, Neurons Afferent : drug effects : enzymology, Neurotrophin 3 : metabolism : pharmacology, Sciatic Nerve : injuries : surgery, Support Non-U.S. Gov't
in
Journal of Neuroscience Research
volume
67
issue
1
pages
62 - 68
publisher
John Wiley and Sons
external identifiers
  • wos:000173098800007
  • pmid:11754081
  • scopus:0036142612
ISSN
1097-4547
DOI
10.1002/jnr.10073
language
English
LU publication?
yes
additional info
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Animal Physiology (Closed 2011) (011011000), Ophthalmology (Lund) (013043000)
id
7c782009-823f-4e29-95f5-780d57a44ff4 (old id 106949)
alternative location
http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11754081&dopt=Abstract
date added to LUP
2016-04-01 16:56:37
date last changed
2021-01-06 03:47:38
@article{7c782009-823f-4e29-95f5-780d57a44ff4,
  abstract     = {PD98059 blocks mitogen-activated protein kinase (MAPK) by inhibiting its activator, MAP kinase kinase (MEK). We have previously found that PD98059 only transiently inhibits spontaneous axonal outgrowth from adult mouse dorsal root ganglia (DRG) explants, whereas it causes sustained inhibition of nerve growth factor (NGF)-stimulated growth. Surprisingly, the present results showed that outgrowth stimulation by neurotrophin-3 (NT-3), interacting with another neuronal subgroup, was markedly enhanced by PD98059 and also by U0126, another inhibitor of MAPK activation. In contrast, the effects of glial cell line-derived neurotrophic factor (GDNF), which stimulates still another subgroup of DRG neurons, was opposed by PD98059. Axonal outgrowth in vitro can also be strongly increased by a prior axotomy in vivo. The increased outgrowth in preaxotomized explants was effectively inhibited by the presence of PD98059. Immunocytochemistry based on whole-mount labelling revealed the presence of neuronal MAPK, which was found to be activated by NGF, NT-3, and GDNF in separate axonal populations and by a prior axotomy in a majority of growing axons. The results suggest that there are important differences in the NGF and NT-3 signalling pathways, which may involve positive and negative control mechanisms by MAPK activation, respectively. Other findings indicate that GDNF exerts its growth effects by activation of MAPK and that expression of the conditioning effect in vitro in preaxotomized preparations also requires activation of MAPK.},
  author       = {Wiklund, Peter and Ekström, Per and Edström, Anders},
  issn         = {1097-4547},
  language     = {eng},
  number       = {1},
  pages        = {62--68},
  publisher    = {John Wiley and Sons},
  series       = {Journal of Neuroscience Research},
  title        = {Mitogen-activated protein kinase inhibition reveals differences in signalling pathways activated by neurotrophin-3 and other growth-stimulating conditions of adult mouse dorsal root ganglia neurons.},
  url          = {http://dx.doi.org/10.1002/jnr.10073},
  doi          = {10.1002/jnr.10073},
  volume       = {67},
  year         = {2002},
}